Kohlberg Kravis Roberts & Co’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-14,435	Closed	-$208K	–	206
2021 Q2	$208K	Hold	14,435	–	–	﹤0.01%	134
2021 Q1	$62K	Buy	+14,435	New	+$65.3K	﹤0.01%	101

Kohlberg Kravis Roberts & Co's CEREW Position: Q3 2021 in Review

Kohlberg Kravis Roberts & Co sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 14,435 shares — an estimated $208K sold.

Kohlberg Kravis Roberts & Co first reported a position in CEREW in Q1 2021 and held it in 2 quarters. The position peaked at $208K in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Kohlberg Kravis Roberts & Co reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Kohlberg Kravis Roberts & Co sold 14,435 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $208K.
Kohlberg Kravis Roberts & Co first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q1 2021 and held it in 2 quarters.
Kohlberg Kravis Roberts & Co's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $208K in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2021, filed 15 Nov 2021.